Viking Therapeutics: Overdue For Gains (NASDAQ:VKTX)

Group 1 - The article discusses the potential for undervalued stocks that are mispriced by the market as the end of Q3 approaches [1] - It suggests that investors may consider joining a platform for insights on these investment opportunities [1] Group 2 - There is a mention of a specific company, VKTX, indicating a potential interest in initiating a long position through stock or options purchases within the next 72 hours [2] - The article emphasizes that the opinions expressed are those of the author and not influenced by any compensation from companies mentioned [2]